Anish Patel, the Chief Operating Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), recently sold shares in the company amounting to $146,205. The transaction involved the sale of 6,667 shares of ...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...
Benjamin Hohl, the Chief Financial Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), a biotechnology company with a market capitalization of $1.07 billion, recently executed a series of stock ...
Enliven Therapeutics, Inc. (ELVN) stock price is 21.86 and Enliven Therapeutics, Inc. (ELVN) 10-day simple moving average is 21.57. Enliven Therapeutics, Inc. (ELVN) stock price is 21.86 and ...
After-Hours Stock Movers: Imara Inc (NASDAQ:IMRA) 19% HIGHER; Enliven Therapeutics, Inc., a clinical-stage precision oncology company focused on the discovery and development of... Investing.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback